Log in

Relevant bibliographies by topics / Hai yang sheng wu / Journal articles

To see the other types of publications on this topic, follow the link: Hai yang sheng wu.

Journal articles on the topic 'Hai yang sheng wu'

Author: Grafiati

Published: 11 December 2022

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Hai yang sheng wu.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Yu, Yang, Mei-Fen Bao, Sheng-Zhuo Huang, Jing Wu, and Xiang-Hai Cai. "Vincan- and eburnan-type alkaloids from Tabernaemontana bovina and their hypoglycemic activity." Phytochemistry 190 (October 31, 2021): 1–11. https://doi.org/10.1016/j.phytochem.2021.112859.

Full text

Abstract:

Yu, Yang, Bao, Mei-Fen, Huang, Sheng-Zhuo, Wu, Jing, Cai, Xiang-Hai (2021): Vincan- and eburnan-type alkaloids from Tabernaemontana bovina and their hypoglycemic activity. Phytochemistry (112859) 190: 1-11, DOI: 10.1016/j.phytochem.2021.112859, URL: http://dx.doi.org/10.1016/j.phytochem.2021.112859

APA, Harvard, Vancouver, ISO, and other styles

2

Sheng, Mao-Ling, Shu-Ping Sun, Xi-Nan Wang, and Hai-Wei Wu. "A new genus and species of subfamily Banchinae (Hymenoptera, Ichneumonidae) from China." Zootaxa 4413, no. 3 (2018): 541–50. https://doi.org/10.11646/zootaxa.4413.3.8.

Full text

Abstract:

Sheng, Mao-Ling, Sun, Shu-Ping, Wang, Xi-Nan, Wu, Hai-Wei (2018): A new genus and species of subfamily Banchinae (Hymenoptera, Ichneumonidae) from China. Zootaxa 4413 (3): 541-550, DOI: 10.11646/zootaxa.4413.3.8

APA, Harvard, Vancouver, ISO, and other styles

3

Li, Cheng-Sheng, Hai-Song Wu, Wen-Qun Fei, and Chen Ren. "Validation of the name Gynura villosa (Asteraceae-Senecioneae)." Phytotaxa 570, no. 2 (2022): 229–30. https://doi.org/10.11646/phytotaxa.570.2.9.

Full text

Abstract:

Li, Cheng-Sheng, Wu, Hai-Song, Fei, Wen-Qun, Ren, Chen (2022): Validation of the name Gynura villosa (Asteraceae-Senecioneae). Phytotaxa 570 (2): 229-230, DOI: 10.11646/phytotaxa.570.2.9, URL: http://dx.doi.org/10.11646/phytotaxa.570.2.9

APA, Harvard, Vancouver, ISO, and other styles

4

Chen, You-Sheng, Chun-Lei Xiang, Jian-Yong Wu, Jun-Jie Liao, and Hai-Lei Zheng. "Hanceola yuanyangensis (Lamiaceae, Nepetoideae), a new species from Yunnan, China." Phytotaxa 480, no. 3 (2021): 297–300. https://doi.org/10.11646/phytotaxa.480.3.10.

Full text

Abstract:

Chen, You-Sheng, Xiang, Chun-Lei, Wu, Jian-Yong, Liao, Jun-Jie, Zheng, Hai-Lei (2021): Hanceola yuanyangensis (Lamiaceae, Nepetoideae), a new species from Yunnan, China. Phytotaxa 480 (3): 297-300, DOI: 10.11646/phytotaxa.480.3.10, URL: http://dx.doi.org/10.11646/phytotaxa.480.3.10

APA, Harvard, Vancouver, ISO, and other styles

5

Duan, Chun-Hua, Tao Li, Hai-Wei Wu, and Mao-Ling Sheng. "A new species of genus Endasys Förster (Ichneumonidae, Cryptinae) parasitizing Pristiphora (Tenthredinidae) and a key to species from China." Zootaxa 4743, no. 1 (2020): 111–18. https://doi.org/10.11646/zootaxa.4743.1.9.

Full text

Abstract:

Duan, Chun-Hua, Li, Tao, Wu, Hai-Wei, Sheng, Mao-Ling (2020): A new species of genus Endasys Förster (Ichneumonidae, Cryptinae) parasitizing Pristiphora (Tenthredinidae) and a key to species from China. Zootaxa 4743 (1): 111-118, DOI: 10.11646/zootaxa.4743.1.9

APA, Harvard, Vancouver, ISO, and other styles

6

Li, Cheng-Sheng, Hai-Song Wu, Wen-Qun Fei, and Chen Ren. "Clarification of the taxonomic and nomenclatural confusion about Arnica japonica L. f. and A. japonica Thunb. (Asteraceae: Senecioneae)." Phytotaxa 570, no. 2 (2022): 217–22. https://doi.org/10.11646/phytotaxa.570.2.7.

Full text

Abstract:

Li, Cheng-Sheng, Wu, Hai-Song, Fei, Wen-Qun, Ren, Chen (2022): Clarification of the taxonomic and nomenclatural confusion about Arnica japonica L. f. and A. japonica Thunb. (Asteraceae: Senecioneae). Phytotaxa 570 (2): 217-222, DOI: 10.11646/phytotaxa.570.2.7, URL: http://dx.doi.org/10.11646/phytotaxa.570.2.7

APA, Harvard, Vancouver, ISO, and other styles

7

Yuan, Yuan, Fang Wu, Yu-Cheng Dai, Wen-Min Qin, and Hai-Sheng Yuan. "Odontia aculeata and O. sparsa, two new species of tomentelloid fungi (Thelephorales, Basidiomycota) from the secondary forests of northeast China." Phytotaxa 372, no. 3 (2018): 183–92. https://doi.org/10.11646/phytotaxa.372.3.1.

Full text

Abstract:

Yuan, Yuan, Wu, Fang, Dai, Yu-Cheng, Qin, Wen-Min, Yuan, Hai-Sheng (2018): Odontia aculeata and O. sparsa, two new species of tomentelloid fungi (Thelephorales, Basidiomycota) from the secondary forests of northeast China. Phytotaxa 372 (3): 183-192, DOI: 10.11646/phytotaxa.372.3.1, URL: http://dx.doi.org/10.11646/phytotaxa.372.3.1

APA, Harvard, Vancouver, ISO, and other styles

8

Hamilton, Erika P., Jianqing Zhu, Wu Zhuang, et al. "Abstract 648: Activity of BNT327/PM8002 (PD-L1 x VEGF-A bispecific antibody) in combination with BNT325/DB-1305 (TROP2 ADC) in solid tumors: Early preclinical and clinical evidence to support BNT327 + ADC combinations." Cancer Research 85, no. 8_Supplement_1 (2025): 648. https://doi.org/10.1158/1538-7445.am2025-648.

Full text

Abstract:

Abstract Emerging data suggest that IO-ADC combinations may lead to better patient outcomes. BNT327 (also known as PM8002) is an investigational anti-PD-L1 x VEGF-A bispecific antibody that has shown encouraging efficacy and tolerability across tumor types, including “cold” tumors not generally responsive to IO therapies (eg, low PD-L1 levels) (Wu J, SABCS 2024 PS3-08; Wu YL, ESMO 2024 1255MO). BNT325 (also known as DB-1305) is an investigational topoisomerase-I-inhibitor-based anti-TROP2 ADC that has so far shown manageable safety and encouraging early clinical activity (Rubinstein M, SGO 202

APA, Harvard, Vancouver, ISO, and other styles

9

Li, Ziming, Xiaomin Dang, Dingzhi Huang, et al. "Abstract CT246: Open-label, single-arm, multicenter, phase 2 trial of garsorasib in KRAS G12C-mutated non-small-cell lung cancer." Cancer Research 84, no. 7_Supplement (2024): CT246. http://dx.doi.org/10.1158/1538-7445.am2024-ct246.

Full text

Abstract:

Abstract Background: Garsorasib (D-1553), a potent KRAS G12C inhibitor, has previously demonstrated promising anti-tumor activity in KRAS G12C-mutated non-small-cell lung cancer (NSCLC) in a phase 1 study. Here we present the efficacy and safety of garsorasib in a pivotal phase 2 study. Methods: In this open-label, multicenter, single-arm phase 2 study, patients received garsorasib 600 mg twice daily in 21-day cycles. Eligible criteria included patients with locally advanced or metastatic NSCLC harboring KRAS G12C mutation, who had disease progression after prior anti-PD-(L)1 therapy and plati

APA, Harvard, Vancouver, ISO, and other styles

10

Chen, Shun-Qing, Jia Jia, Jing-Yao Hu, et al. "Iboga-type alkaloids with Indolizidino[8,7-b]Indole scaffold and bisindole alkaloids from Tabernaemontana bufalina Lour." Phytochemistry 196 (April 30, 2022): 1–11. https://doi.org/10.1016/j.phytochem.2022.113089.

Full text

Abstract:

Chen, Shun-Qing, Jia, Jia, Hu, Jing-Yao, Wu, Jun, Sun, Wen-Ting, Zheng, Mingxin, Wang, Xi, Zhu, Kong-Kai, Jiang, Cheng-Shi, Yang, Sheng-Ping, Zhang, Juan, Wang, Shou-Bao, Cai, You-Sheng (2022): Iboga-type alkaloids with Indolizidino[8,7-b]Indole scaffold and bisindole alkaloids from Tabernaemontana bufalina Lour. Phytochemistry (113089) 196: 1-11, DOI: 10.1016/j.phytochem.2022.113089, URL: http://dx.doi.org/10.1016/j.phytochem.2022.113089

APA, Harvard, Vancouver, ISO, and other styles

11

Hou, Mian, Yunke Wu, Kelin Yang, Sheng Zheng, Zhiyong Yuan, and Pipeng Li. "A missing geographic link in the distribution of the genus Echinotriton (Caudata: Salamandridae) with description of a new species from southern China." Zootaxa 3895, no. 1 (2014): 89–102. https://doi.org/10.11646/zootaxa.3895.1.5.

Full text

Abstract:

Hou, Mian, Wu, Yunke, Yang, Kelin, Zheng, Sheng, Yuan, Zhiyong, Li, Pipeng (2014): A missing geographic link in the distribution of the genus Echinotriton (Caudata: Salamandridae) with description of a new species from southern China. Zootaxa 3895 (1): 89-102, DOI: 10.11646/zootaxa.3895.1.5

APA, Harvard, Vancouver, ISO, and other styles

12

Liu, Yi-Fan, Sheng-Chuan Yang, Jun-Jie Gu, and Hai-Jian Wang. "Two new species of Interphasma Chen & He, 2008 (Phasmatodea: Phasmatidae: Clitumninae) from Yunnan, China." Zootaxa 5446, no. 4 (2024): 531–41. https://doi.org/10.11646/zootaxa.5446.4.5.

Full text

Abstract:

Liu, Yi-Fan, Yang, Sheng-Chuan, Gu, Jun-Jie, Wang, Hai-Jian (2024): Two new species of Interphasma Chen & He, 2008 (Phasmatodea: Phasmatidae: Clitumninae) from Yunnan, China. Zootaxa 5446 (4): 531-541, DOI: 10.11646/zootaxa.5446.4.5, URL: http://dx.doi.org/10.11646/zootaxa.5446.4.5

APA, Harvard, Vancouver, ISO, and other styles

13

Liu, Xin, Jing Fu, Rong-Sheng Shen, et al. "Linderanoids A-O, dimeric sesquiterpenoids from the roots of Lindera aggregata (Sims) Kosterm." Phytochemistry 191 (November 30, 2021): 1–9. https://doi.org/10.1016/j.phytochem.2021.112924.

Full text

Abstract:

Liu, Xin, Fu, Jing, Shen, Rong-Sheng, Wu, Xu-Jia, Yang, Ji, Bai, Li-Ping, Jiang, Zhi-Hong, Zhu, Guo-Yuan (2021): Linderanoids A-O, dimeric sesquiterpenoids from the roots of Lindera aggregata (Sims) Kosterm. Phytochemistry (112924) 191: 1-9, DOI: 10.1016/j.phytochem.2021.112924, URL: http://dx.doi.org/10.1016/j.phytochem.2021.112924

APA, Harvard, Vancouver, ISO, and other styles

14

Jiao, Jiahang. "Analysis on the Artistic Characteristics of Sheng Solo "Lin Hai New Song"." International Journal of Education and Humanities 3, no. 2 (2022): 36–38. http://dx.doi.org/10.54097/ijeh.v3i2.613.

Full text

Abstract:

The sheng solo piece "Lin Hai New Song" was composed by Tang Fu and Mr. Gao Yang in 1975. It uses the labor horn in the forest area as the keynote of the piece. The musical emotion is firm and powerful and the rhythm is clear. The heroic image also depicts the magnificent scene of towering trees falling down the mountain. In addition to the traditional single melody expression, this piece also uses polyphonic techniques to enrich the color of the performance and make the artistic expression more colorful. The piece highlights the ideology under the social background at that time, and it is one

APA, Harvard, Vancouver, ISO, and other styles

15

Huang, Dong-Dong, Chen-Yang Shen, Gui-Ying Huang, et al. "A new species of Isonychia Eaton, 1871 (Ephemeroptera: Isonychiidae) from Taishun, China based on morphological characteristics and COX1 gene." Zootaxa 5437, no. 4 (2024): 537–48. https://doi.org/10.11646/zootaxa.5437.4.6.

Full text

Abstract:

Huang, Dong-Dong, Shen, Chen-Yang, Huang, Gui-Ying, Ye, Lin-Yu, Wu, Hui-Yuan, Zhang, Shu-Sheng, Cheng, Hong-Yi (2024): A new species of Isonychia Eaton, 1871 (Ephemeroptera: Isonychiidae) from Taishun, China based on morphological characteristics and COX1 gene. Zootaxa 5437 (4): 537-548, DOI: 10.11646/zootaxa.5437.4.6, URL: http://dx.doi.org/10.11646/zootaxa.5437.4.6

APA, Harvard, Vancouver, ISO, and other styles

16

Төрбат, Цагаан. "Ашина овгийн хатны эртний геном нь Хөх түрэгийн хаант улсыг Зүүн хойд Азийн гаралтай болохыг харуулжээ". Mongolian Journal of Anthropology, Archaeology and Ethnology 13, № 1 (2024): 141–45. http://dx.doi.org/10.22353/mjaae.20241301013.

Full text

Abstract:

Xiao‐Min Yang, Hai‐Liang Meng, Jian‐Lin Zhang, Yao Yu, Edward Allen, Zi‐Yang Xia, Kong‐Yang Zhu, Pan‐Xin Du, Xiao‐Ying Ren, Jian‐Xue Xiong, Xiao‐Yu Lu, Yi Ding, Sheng Han, Wei‐Peng Liu, Li Jin, Chuan‐Chao Wang, and Shao‐Qing Wen. Ancient genome of Empress Ashina reveals the Northeast Asian origin of Göktürk Khanate. – Journal of Systematic and Evolution. Institute of Botany, Chinese Academy of Sciences. 2023. Volume 00 (0) 1-9.

APA, Harvard, Vancouver, ISO, and other styles

17

Lee, Chia-Lin, Chien-Ming Wang, Hao-Chun Hu, et al. "Indole alkaloids indigodoles A-C from aerial parts of Strobilanthes cusia in the traditional Chinese medicine Qing Dai have anti-IL-17 properties." Phytochemistry 162 (March 7, 2019): 39–46. https://doi.org/10.1016/j.phytochem.2019.02.016.

Full text

Abstract:

Lee, Chia-Lin, Wang, Chien-Ming, Hu, Hao-Chun, Yen, Hung-Rong, Song, Ying-Chyi, Yu, Sheng-Jie, Chen, Chao-Jung, Li, Wei-Chu, Wu, Yang-Chang (2019): Indole alkaloids indigodoles A-C from aerial parts of Strobilanthes cusia in the traditional Chinese medicine Qing Dai have anti-IL-17 properties. Phytochemistry 162: 39-46, DOI: 10.1016/j.phytochem.2019.02.016, URL: http://dx.doi.org/10.1016/j.phytochem.2019.02.016

APA, Harvard, Vancouver, ISO, and other styles

18

Yang, Hui, Hiran A. Ariyawansa, Hai-Xia Wu, and Kevin D. Hyde. "The genus Leptoxyphium (Capnodiaceae) from China." Phytotaxa 176, no. 1 (2014): 174–83. https://doi.org/10.11646/phytotaxa.176.1.17.

Full text

Abstract:

Yang, Hui, Ariyawansa, Hiran A., Wu, Hai-Xia, Hyde, Kevin D. (2014): The genus Leptoxyphium (Capnodiaceae) from China. Phytotaxa 176 (1): 174-183, DOI: 10.11646/phytotaxa.176.1.17, URL: http://dx.doi.org/10.11646/phytotaxa.176.1.17

APA, Harvard, Vancouver, ISO, and other styles

19

Wu, Hai-Xia, Yan-Mei Li, Hiran A. Ariyawansa, Wen-Jing Li, Hui Yang, and Kevin D. Hyde. "A new species of Microthyrium from Yunnan, China." Phytotaxa 176, no. 1 (2014): 213–18. https://doi.org/10.11646/phytotaxa.176.1.21.

Full text

Abstract:

Wu, Hai-Xia, Li, Yan-Mei, Ariyawansa, Hiran A., Li, Wen-Jing, Yang, Hui, Hyde, Kevin D. (2014): A new species of Microthyrium from Yunnan, China. Phytotaxa 176 (1): 213-218, DOI: 10.11646/phytotaxa.176.1.21, URL: http://dx.doi.org/10.11646/phytotaxa.176.1.21

APA, Harvard, Vancouver, ISO, and other styles

20

Huang, Qiao-Lan, Hai-Song Wu, Wen-Qun Fei, Qiong Yuan, and Qin-Er Yang. "The identity of Clematis wenxianensis (Ranunculaceae) described from southern Gansu, China." Phytotaxa 625, no. 2 (2023): 142–60. https://doi.org/10.11646/phytotaxa.625.2.2.

Full text

Abstract:

Huang, Qiao-Lan, Wu, Hai-Song, Fei, Wen-Qun, Yuan, Qiong, Yang, Qin-Er (2023): The identity of Clematis wenxianensis (Ranunculaceae) described from southern Gansu, China. Phytotaxa 625 (2): 142-160, DOI: 10.11646/phytotaxa.625.2.2, URL: https://phytotaxa.mapress.com/pt/article/download/phytotaxa.625.2.2/51275

APA, Harvard, Vancouver, ISO, and other styles

21

Wu, Bao-Huan, Wan-Yi Zhao, Hai-Jun Yang, et al. "Prunus yunkaishanensis (Rosaceae), a new species from Guangdong, South China." Phytotaxa 541, no. 3 (2022): 277–84. https://doi.org/10.11646/phytotaxa.541.3.7.

Full text

Abstract:

Wu, Bao-Huan, Zhao, Wan-Yi, Yang, Hai-Jun, Chen, Zhi-Hui, Li, You-Yu, Cui, Da-Fang, Liao, Wen-Bo, Kang, Ming (2022): Prunus yunkaishanensis (Rosaceae), a new species from Guangdong, South China. Phytotaxa 541 (3): 277-284, DOI: 10.11646/phytotaxa.541.3.7, URL: http://dx.doi.org/10.11646/phytotaxa.541.3.7

APA, Harvard, Vancouver, ISO, and other styles

22

Xue, D. "Sheng Wu Duo Yang Xing De Fa Lv Bao Hu [Biodiversity Conservation in Law]." Chinese Journal of International Law 13, no. 2 (2014): 471–75. http://dx.doi.org/10.1093/chinesejil/jmu014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Liu, Qing, Hai-Jun Hu, Peng-Fei Li, et al. "Diterpenoids and phenylethanoid glycosides from the roots of Clerodendrum bungei and their inhibitory effects against angiotensin converting enzyme and -glucosidase." Phytochemistry 103 (July 31, 2014): 196–202. https://doi.org/10.1016/j.phytochem.2014.02.015.

Full text

Abstract:

Liu, Qing, Hu, Hai-Jun, Li, Peng-Fei, Yang, Ying-Bo, Wu, Li-Hong, Chou, Gui-Xin, Wang, Zheng-Tao (2014): Diterpenoids and phenylethanoid glycosides from the roots of Clerodendrum bungei and their inhibitory effects against angiotensin converting enzyme and -glucosidase. Phytochemistry 103: 196-202, DOI: 10.1016/j.phytochem.2014.02.015, URL: http://dx.doi.org/10.1016/j.phytochem.2014.02.015

APA, Harvard, Vancouver, ISO, and other styles

24

Huang, Qiao-Lan, Wen-Qun Fei, Hai-Song Wu, Qiong Yuan, and Qin-Er Yang. "Clematis chengguensis and C. retusifolia (Ranunculaceae), both described from Shaanxi of China, are merged with C. armandi, a widely distributed species in the country." Phytotaxa 669, no. 3 (2024): 211–32. https://doi.org/10.11646/phytotaxa.669.3.3.

Full text

Abstract:

Huang, Qiao-Lan, Fei, Wen-Qun, Wu, Hai-Song, Yuan, Qiong, Yang, Qin-Er (2024): Clematis chengguensis and C. retusifolia (Ranunculaceae), both described from Shaanxi of China, are merged with C. armandi, a widely distributed species in the country. Phytotaxa 669 (3): 211-232, DOI: 10.11646/phytotaxa.669.3.3, URL: https://doi.org/10.11646/phytotaxa.669.3.3

APA, Harvard, Vancouver, ISO, and other styles

25

Jiang, Licui, Changsong Qi, Fengtao You та ін. "Abstract 5255: A B7-H3-CAR-modified Vδ1 T cells showed potentanti-solid tumor potential". Cancer Research 84, № 6_Supplement (2024): 5255. http://dx.doi.org/10.1158/1538-7445.am2024-5255.

Full text

Abstract:

Abstract Background: CAR-αβT cells have made limited advancement in treating solid tumors. Vδ1 T cells, a subtype of γδT cells, are rare in human peripheral blood, but they are the main tissue-resident immune cells found in epithelial and mucosal tissues. This suggests that Vδ1 T cells might be a potential modality for treating solid tumors. To explore this possibility, we hypothesized that Vδ1 T cells modified with B7-H3 CAR (B7-H3-CAR-Vδ1 T) could have great potential of anti-solid tumor activity, making them a promising candidate for further development as a universal cellular therapy produ

APA, Harvard, Vancouver, ISO, and other styles

26

Huang, Qiao-Lan, Wen-Qun Fei, Hai-Song Wu, You-Pai Zeng, Qiong Yuan, and Qin-Er Yang. "Clematis sinii and C. xinhuiensis (Ranunculaceae), respectively described from Guangxi and Guangdong of China, are merged with C. meyeniana, a species widely distributed in eastern and southeastern Asia." Phytotaxa 652, no. 3 (2024): 171–207. https://doi.org/10.11646/phytotaxa.652.3.1.

Full text

Abstract:

Huang, Qiao-Lan, Fei, Wen-Qun, Wu, Hai-Song, Zeng, You-Pai, Yuan, Qiong, Yang, Qin-Er (2024): Clematis sinii and C. xinhuiensis (Ranunculaceae), respectively described from Guangxi and Guangdong of China, are merged with C. meyeniana, a species widely distributed in eastern and southeastern Asia. Phytotaxa 652 (3): 171-207, DOI: 10.11646/phytotaxa.652.3.1, URL: http://dx.doi.org/10.11646/phytotaxa.652.3.1

APA, Harvard, Vancouver, ISO, and other styles

27

Zhang, Jian-Pei, Wen-Rui Li, Shuo Wu, et al. "Prenylated C -C derivatives from the stems and branches of Illicium ternstroemioides A. C. Smith with antiviral activity." Phytochemistry 192 (December 31, 2021): 1–11. https://doi.org/10.1016/j.phytochem.2021.112935.

Full text

Abstract:

Zhang, Jian-Pei, Li, Wen-Rui, Wu, Shuo, Wang, Xiao-Jing, Wang, Ru-Bing, Li, Mi, Su, Guo-Zhu, Wang, Hai-Qiang, Yong, Jin-Yao, Yang, Jia, Li, Li, Li, Yu-Huan, Ma, Shuang-Gang (2021): Prenylated C -C derivatives from the stems and branches of Illicium ternstroemioides A. C. Smith with antiviral activity. Phytochemistry (112935) 192: 1-11, DOI: 10.1016/j.phytochem.2021.112935, URL: http://dx.doi.org/10.1016/j.phytochem.2021.112935

APA, Harvard, Vancouver, ISO, and other styles

28

Wang, Jun-Ling, Hong-Wei Li, Hong-Xia Liu, et al. "Abstract 2108: Comparative analysis of fusion gene detection rates in tissue versus blood samples from Chinese diverse solid tumors." Cancer Research 85, no. 8_Supplement_1 (2025): 2108. https://doi.org/10.1158/1538-7445.am2025-2108.

Full text

Abstract:

Abstract Background: The landscape of genetic alterations, particularly fusion genes, plays a critical role in the diagnosis and treatment of various solid tumors. As liquid biopsy methods evolve, understanding the differences in mutation frequencies between tissue and blood samples becomes essential for precision oncology. This study aimed to evaluate the detection rates of specific fusion genes in both tumor tissue and blood samples from patients with diverse solid tumors using a 733-gene panel through Next-Generation Sequencing (NGS). Methods: We conducted a comprehensive analysis of 23 typ

APA, Harvard, Vancouver, ISO, and other styles

29

Gao, Yue, Chun-Jie Liu, Hua-Yi Li, et al. "Abstract LB168: Platelet RNA signature enables early and accurate detection of ovarian cancer: An intercontinental, biomarker identification study." Cancer Research 82, no. 12_Supplement (2022): LB168. http://dx.doi.org/10.1158/1538-7445.am2022-lb168.

Full text

Abstract:

Abstract Background: Morpho-physiological alternations of platelets provided a rationale to harness RNA sequencing of tumor-educated platelets (TEPs) for preoperative diagnosis of cancer. Timely, accurate, and non-invasive detection of ovarian cancer in women with adnexal masses presents a significant clinical challenge. Patients and Methods: This intercontinental, hospital-based, diagnostic study included 761 treatment-naïve inpatients with histologically confirmed adnexal masses and 167 healthy controls from nine medical centers (China, n=3; Netherlands, n=5; Poland, n=1) between September 2

APA, Harvard, Vancouver, ISO, and other styles

30

Chow, Hei Ching, Tsz Him So, Horace Cheuk Wai Choi, and Ka On Lam. "Literature Review of Traditional Chinese Medicine Herbs–Induced Liver Injury From an Oncological Perspective With RUCAM." Integrative Cancer Therapies 18 (January 2019): 153473541986947. http://dx.doi.org/10.1177/1534735419869479.

Full text

Abstract:

Traditional Chinese medicine (TCM) herbs are commonly regarded to be safe with minimal toxicities in Chinese communities. Cancer patients who are receiving Western oncology therapy often concurrently take TCM herbs for anticancer and symptom relief purposes. We performed a literature review for current evidence on TCM herb–induced liver injury from an oncological perspective. A literature search on PubMed was performed to identify publications regarding TCM herbs and concoctions with hepatoprotective or hepatotoxic properties. Lists of commonly used herbs and their causality levels were compil

APA, Harvard, Vancouver, ISO, and other styles

31

Pei, Jiang. "On Translations and Translators of I. A. Krylov’s Fables in China." Izvestiia Rossiiskoi akademii nauk. Seriia literatury i iazyka 81, no. 1 (2022): 90. http://dx.doi.org/10.31857/s160578800018926-4.

Full text

Abstract:

The article gives a overview of translations of I.A. Krylov’s fables in China. The first of them appeared more than 120 years ago, but the real acquaintance of Chinese readers with his work took place in the 1950s because of the translations of Meng Hai and Wu Yan. From the late 1970s to the present, the number of translations and editions of Krylov’s fables has been constantly increasing. Now in China there are more than 300 separate editions of his selected fables and 33 complete collections. At various times, at least 64 translators worked on translations of Krylov’s fables into Chinese, an

APA, Harvard, Vancouver, ISO, and other styles

32

Pushkarskaya, Natalya. "Chinese Epistemic Culture on the Example of Traditional Chinese Medicine." Ideas and Ideals 14, no. 1-1 (2022): 50–67. http://dx.doi.org/10.17212/2075-0862-2022-14.1.1-50-67.

Full text

Abstract:

The article examines the main features of the epistemic culture of Ancient China and designates its place in the modern theory of knowledge. The author shows a close connection between the method of cognition and the holistic worldview expressed by the proto-categorical conceptual constructions yin - yang 阴阳 (two fundamental opposites), san cai 三才 (heaven - man - earth) and wu xing 五行 (five forces: water - fire - wood - metal - soil). The interrelation between the strategy of cognition and the general socio-cultural paradigm can be most clearly traced on the example of the phenomenon of tradit

APA, Harvard, Vancouver, ISO, and other styles

33

Chiu, Patrick. "From Hai Yao, Yang Yao to Xi Yao: Sinification of Material Medical from the West." Chinese Medicine and Culture 6, no. 4 (2023): 319–29. http://dx.doi.org/10.1097/mc9.0000000000000088.

Full text

Abstract:

In ancient China, Daoist philosophers developed the concepts of qi (energy), Wu Xing (five elements), and yin (feminine, dark, negative) and yang (masculine, bright, positive) opposite forces between 200 and 600 BCE. Based on these philosophies, Zhen Jiu (acupuncture), Ben Cao (materia medica), and the practice of Qi Gong (energy optimization movements) evolved as the three interrelated therapeutic regimens of Chinese medicine (Note 1). Since the time of Zhang Qian, who discovered China’s western regions in the 1st century BCE, Hai Yao (the exotic elements of materia medica from the maritime S

APA, Harvard, Vancouver, ISO, and other styles

34

Shen, John. "New Thoughts on the Use of Chinese Documents in the Reconstruction of Early Swahili History." History in Africa 22 (January 1995): 349–58. http://dx.doi.org/10.2307/3171921.

Full text

Abstract:

For a long time, scholars have known that the ancient Sino-East Africantrade relationship produced valuable accounts of East Africa in the Chinese imperial archives. Particularly, the historical documents compiled during the T'ang, Sung, and Ming dynasties contain several insightful snapshots of East Africa over the span of 800 years. Unfortunately, due to the difficulty of translating ancient Chinese texts, scholars have not been able to utilize these documents fully. In other cases, scholars have misused the translations to derive conclusions that may not be supported by the original text. I

APA, Harvard, Vancouver, ISO, and other styles

35

Huang, Chang-Yu, Yin-Hsuan Chung, Sheng-Yang Wu, et al. "Abstract 1602: Co-targeting mitochondria and nucleotide metabolism in T315I-BCR-ABL myeloid leukemia for therapy." Cancer Research 83, no. 7_Supplement (2023): 1602. http://dx.doi.org/10.1158/1538-7445.am2023-1602.

Full text

Abstract:

Abstract T315I mutation of Bcr-Abl in chronic myeloid leukemia (CML) leads to therapeutic resistance. It is known that Bcr-Abl transformation causes ROS-induced DNA damage, which can be exploited for anti-nucleotide treatment. We developed a small compound, JMF4073, which inhibits pyrimidylate kinases. Intriguingly, treatment of JMF4073 selectively eliminated WT-, but not T315I-, Bcr-Abl-transformed cells. We found that the higher level of cellular glutathione(GSH) in T315I-Bcr-Abl cells confers replication fork progression and sustains dTTP pool, leading to JMF4073 insusceptibility. Blocking

APA, Harvard, Vancouver, ISO, and other styles

36

Wu, Zhuoxun, Qiu-Xu Teng, Yuqi Yang, et al. "Abstract 409: Reversal of ABCG2-mediated multidrug resistance by tepotinib in vitro and in vivo." Cancer Research 82, no. 12_Supplement (2022): 409. http://dx.doi.org/10.1158/1538-7445.am2022-409.

Full text

Abstract:

Abstract ABCG2/BCRP transporter-mediated Multidrug resistance (MDR) in cancers has been considered as one of the obstacles to the cancer chemotherapy. Our recent study characterized the MET inhibitor tepotinib as a potent ABCB1 inhibitor. In the present study, we demonstrated the MET inhibitor tepotinib effectively antagonized ABCG2-mediated MDR in vitro and in vivo. In addition, the ABCB1/ABCG2 double-transfected cell model demonstrated that tepotinib can simultaneously inhibit the two MDR transporters. Mechanistically, tepotinib stimulated ABCG2 ATPase activity without altering the protein e

APA, Harvard, Vancouver, ISO, and other styles

37

Dudek, Julia, Mikołaj Rogalski, Julianna Winnik, Piotr Arcab, Piotr Zdańkowski, and Maciej Trusiak. "Autofocusing method for lensless digital in-line holographic microscopy with misaligned illumination." Photonics Letters of Poland 16, no. 4 (2024): 79–81. https://doi.org/10.4302/plp.v16i4.1306.

Full text

Abstract:

This study presents a correction method in Lensless Digital In-line Holographic Microscopy accounting for tilted illumination to address challenges caused by misalignments in the optical setup. An autofocusing method is discussed, utilizing a sharpness criterion based on amplitude variance to find both propagation distance and illumination tilt for precise holographic reconstruction of phase objects. The proposed algorithm was rigorously tested under large illumination angles, demonstrating its effectiveness in maintaining high reconstruction quality for demanding imaging scenarios. Full Text:

APA, Harvard, Vancouver, ISO, and other styles

38

Yang, Yuqi, Zhuo-Xun Wu, Jing-Quan Wang, et al. "Abstract 407: OTS964, a TOPK inhibitor, is susceptible to ABCG2-mediated drug resistance." Cancer Research 82, no. 12_Supplement (2022): 407. http://dx.doi.org/10.1158/1538-7445.am2022-407.

Full text

Abstract:

Abstract The overexpression of ATP-binding cassette (ABC) transporters has known to be one of the most important mechanisms responsible for the development of multidrug resistance (MDR). OTS964 is a potent T-LAK cell-originated protein kinase (TOPK) inhibitor. Herein, we investigated the interaction of OTS964 and MDR-associated ATP-binding cassette sub-family G member 2 (ABCG2, breast cancer resistance protein/BCRP). The cell viability assay indicated that the effectiveness of OTS964 is limited in drug-resistant and gene-transfected cells overexpressing ABCG2. We found that the known ABCG2 inh

APA, Harvard, Vancouver, ISO, and other styles

39

Zhang, Xu, Marimikel Charrier, and Caroline M. Ajo-Franklin. "Multichannel Bioelectronic Sensing: Binary Encoding of Environmental Contaminants." ECS Meeting Abstracts MA2024-02, no. 64 (2024): 4260. https://doi.org/10.1149/ma2024-02644260mtgabs.

Full text

Abstract:

Environmental water contamination from natural and synthetic chemicals is a pressing global issue. Addressing this requires the development of portable, selective, and accurate sensors. Biosensors, particularly whole-cell bioelectronic sensors, are promising due to their ability to convert chemical signals into electrical signals via extracellular electron transfer (EET) pathways. However, these sensors typically employ a single electron transfer pathway as an electrochemical channel, limiting them to the detection of a single analyte (Atkinson et al. 2022). To expand the information content,

APA, Harvard, Vancouver, ISO, and other styles

40

Cheng, Ying, Lin Shen, Zhendong Chen, et al. "Abstract CT225: Surufatinib plus toripalimab for first-line treatment of advanced non-small cell lung cancer (NSCLC) with PD-L1 positive expression: A multicenter, single-arm phase 2 study." Cancer Research 83, no. 8_Supplement (2023): CT225. http://dx.doi.org/10.1158/1538-7445.am2023-ct225.

Full text

Abstract:

Abstract Background: Surufatinib (S, a small-molecule inhibitor of VEGFR 1-3, FGFR1 and CSF-1R) plus toripalimab (T, an anti-PD-1 antibody) showed encouraging antitumor activity in solid tumors (Cao YS, 2022). Programmed death ligand 1 (PD-L1) expression is the established biomarker for 1L immune checkpoint inhibitors therapy in advanced NSCLC. We conducted an open-label, multi-cohort, single-arm phase 2 study to evaluate the safety and efficacy of S+T in patients (pts) with advanced solid tumors. Here, we reported the results of advanced NSCLC with PD-L1 positive expression cohort. Methods: E

APA, Harvard, Vancouver, ISO, and other styles

41

Tan, Zi Ching, Yang Wu, Zhen Wei Neo, et al. "Abstract 151: Spatial patterns of APOBEC mutagenesis in the tumor microenvironment of Asian breast cancer." Cancer Research 85, no. 8_Supplement_1 (2025): 151. https://doi.org/10.1158/1538-7445.am2025-151.

Full text

Abstract:

Abstract A common germline polymorphism in chromosome 22 involves the deletion of a large portion of the APOBEC3B gene that results in an APOBEC3A-B hybrid transcript. The hybrid transcript increases APOBEC3A activity and therefore increases APOBEC-associated mutagenesis, which is a common and important mutational signature in cancers. This deletion polymorphism is found with higher prevalence in Asians and is associated with increased risk of breast cancer in Asian women, as well as development of hypermutated cancers with greater immune cell infiltration. We used Stereo-seq spatial transcrip

APA, Harvard, Vancouver, ISO, and other styles

42

Wu, Xiaojuan, Mingyue Shen, Mo Dan, et al. "Abstract 4337: SYS6051, a next-generation tissue factor-targeted antibody-drug conjugates for the treatment of TF-expressing malignancies." Cancer Research 85, no. 8_Supplement_1 (2025): 4337. https://doi.org/10.1158/1538-7445.am2025-4337.

Full text

Abstract:

Abstract Tissue factor (TF) is an integral membrane protein, normally separated from the blood by the vascular endothelium, which plays a key role in the initiation of blood coagulation. However, TF is aberrantly expressed in solid tumors and its expression associated with poor prognosis. The first TF targeting antibody-drug conjugate (ADC) , a microtubule inhibitor based ADC(MTI-ADC), is approved for the treatment of cervical cancer. It had several prespecified adverse effects (AEs) including bleeding risks, ocular toxicity and perpheral neuropathy, the last two of which were known MMAE relat

APA, Harvard, Vancouver, ISO, and other styles

43

Dai, Ming-Shen, Chih-Chiang Hung, Liang-Chih Liu, et al. "Abstract P1-12-03: Clinical Efficacy and Outcomes of Astragalus Polysaccharides (PG2) toward Cancer-related Fatigue of Advanced Breast Cancer Patients." Clinical Cancer Research 31, no. 12_Supplement (2025): P1–12–03—P1–12–03. https://doi.org/10.1158/1557-3265.sabcs24-p1-12-03.

Full text

Abstract:

Abstract Background: Cancer-related Fatigue (CRF) is the most prevalent and disturbing symptom among breast cancer patients. Astragalus Polysaccharides (PG2, PhytoHealth Corporation, Taiwan) is a drug approved for CRF treatment and marketed in Taiwan. In the PG2 phase IV clinical trial demonstrated that PG2 improved CRF in over 60% of cancer patients, particularly significant in the breast cancer subgroup. Then PG2 got reimbursement from National Health Insurance of Taiwan. The aim of this study was to assess the real-world treatment efficacy of CRF by PG2 among advanced breast cancer patients

APA, Harvard, Vancouver, ISO, and other styles

44

Fang, Wenfeng, Ning Li, Runxiang Yang, et al. "Abstract 511: Neratinib monotherapy in advanced non-small cell lung cancer with EGFR exon 18 mutations in China." Cancer Research 85, no. 8_Supplement_1 (2025): 511. https://doi.org/10.1158/1538-7445.am2025-511.

Full text

Abstract:

Abstract Background: In NSCLC patients, EGFR exon 18 mutations account for approximately 3-5% and are associated with a poor prognosis. In phase 2 SUMMIT global trial, 29 metastatic NSCLC patients with EGFR exon 18 mutations received neratinib monotherapy, having good result. The objective response rate (ORR) was 35%. However, only 1 (4.5%) Asian individual is enrolled in study. Therefore, there is an urgent need to explore the effect of neratinib monotherapy in Chinese NSCLC patients with EGFR exon 18 mutation. Methods: Planned 14 patients with EGFR exon 18-mutated NSCLC who had failed first-

APA, Harvard, Vancouver, ISO, and other styles

45

Shao, Zhi-Ming, Li Chen, Hui Li, et al. "Abstract GS3-06: Neoadjuvant camrelizumab plus chemotherapy (chemo) for early or locally advanced triple-negative breast cancer (TNBC): a randomized, double-blind, phase 3 trial." Clinical Cancer Research 31, no. 12_Supplement (2025): GS3–06—GS3–06. https://doi.org/10.1158/1557-3265.sabcs24-gs3-06.

Full text

Abstract:

Abstract Background: For early or locally advanced TNBC, preferred neoadjuvant strategies include a four-drug chemotherapy regimen containing anthracyclines, cyclophosphamide, taxanes, and platinum. Accumulating evidence suggests that blockade of the PD-1/PD-L1 pathway may enhance the efficacy of conventional neoadjuvant chemotherapy. Camrelizumab is an anti-PD-1 antibody that has demonstrated antitumor activity in advanced or metastatic TNBC. Herein, we conducted a double-blind, randomized phase 3 trial (NCT04613674) to evaluate the efficacy and safety of neoadjuvant camrelizumab plus chemo i

APA, Harvard, Vancouver, ISO, and other styles

46

Chen, Li, Yi-Zhou Jiang, Songyang Wu, et al. "Abstract P2-14-04: Updated data from FUTURE-C-PLUS: Combination of famitinib with camrelizumab plus nab-paclitaxel as first-line treatment for advanced, immunomodulatory triple-negative breast cancer, an open-label, single-arm, phase 2 trial." Cancer Research 82, no. 4_Supplement (2022): P2–14–04—P2–14–04. http://dx.doi.org/10.1158/1538-7445.sabcs21-p2-14-04.

Full text

Abstract:

Abstract Background Camrelizumab and nab-paclitaxel demonstrated promising anti-tumour activity in refractory metastatic immunomodulatory triple-negative breast cancer (TNBC) in FUTURE trial. Anti-angiogenic agents have been reported to facilitate immune infiltration. Famitinib is a tyrosine kinase inhibitor targeting VEGFR-2, PDGFR and c-kit. The FUTURE-C-PLUS trial (NCT04129996) which added famitinib to camrelizumab and nab-paclitaxel is a single-arm, phase 2 trial evaluating this novel triplet combinatorial strategy in patients with advanced immunomodulatory TNBC. Study design and the prima

APA, Harvard, Vancouver, ISO, and other styles

47

Peng, Zhi, Hua Wang, Baorui Liu, et al. "Abstract CT152: A multicenter Phase II study of savolitinib in patients with MET-amplified gastroesophogeal junction adenocarcinomas or gastric cancer." Cancer Research 83, no. 8_Supplement (2023): CT152. http://dx.doi.org/10.1158/1538-7445.am2023-ct152.

Full text

Abstract:

Abstract Background: MET gene amplification is associated with poor prognosis in gastric cancer (GC) and gastroesophageal junction adenocarcinomas (GEJ). Savolitinib is a potent and highly selective oral MET tyrosine-kinase inhibitor. Here we reported the preliminary efficacy and safety from a phase 2 trial of savolitinib monotherapy in patients (pts) with MET-amplified advanced or metastatic GC/GEJ. (NCT04923932). Methods: Eligible pts had 2L+ GEJ or GC, with MET amplification and measurable lesions. Pts received savolitinib at 600 mg QD for body weight (BW) ≥50 kg, while 400 mg QD for BW &am

APA, Harvard, Vancouver, ISO, and other styles

48

Fang, Yin-Ying, Chi-Fang Chen, and Sheng-Ju Wu. "Feature identification using acoustic signature of Ocean Researcher III (ORIII) of Taiwan." ANZIAM Journal 59 (July 25, 2019): C318—C357. http://dx.doi.org/10.21914/anziamj.v59i0.12655.

Full text

Abstract:

Underwater acoustic signature identification has been employed as a technique for detecting underwater vehicles, such as in anti-submarine warfare or harbour security systems. The underwater sound channel, however, has interference due to spatial variations in topography or sea state conditions and temporal variations in water column properties, which cause multipath and scattering in acoustic propagation. Thus, acoustic data quality control can be very challenging. One of challenges for an identification system is how to recognise the same target signature from measurements under different te

APA, Harvard, Vancouver, ISO, and other styles

49

Yu Mu, Hsuan, Yen-Nhi Ngoc Ta, Jing Rui Max Tham, et al. "Abstract 5737: Enhancing cancer treatment Via a nanostructured chemoimmunotherapy gel facilitating interleukin-2 delivery and immunogenic cell death induction." Cancer Research 84, no. 6_Supplement (2024): 5737. http://dx.doi.org/10.1158/1538-7445.am2024-5737.

Full text

Abstract:

Abstract Background: The landscape of immunotherapy, employing recombinant cytokines like interleukin-2 (IL-2), confronts challenges marked by its short half-life, systemic toxicity, and constrained tumor accumulation. These hurdles are particularly evident in the context of the immunosuppressive milieu characterizing pancreatic ductal adenocarcinoma (PDAC). Chemo-immuno-therapeutic synergies, notably those provoking immunogenic cell death (ICD), have demonstrated superior efficacy. This investigation delves into Pt-NHC as a type II ICD inducer to surmount immunosuppression and amplify antitum

APA, Harvard, Vancouver, ISO, and other styles

50

Mai, Hai-Qiang, Ya-Qian Han, Guo-Wu Wu, et al. "Abstract CT113: A dose-exploring, randomized, open-label, Phase I study for toripalimab subcutaneous injection in patients with advanced nasopharyngeal carcinoma." Cancer Research 84, no. 7_Supplement (2024): CT113. http://dx.doi.org/10.1158/1538-7445.am2024-ct113.

Full text

Abstract:

Abstract Background Toripalimab, a humanized IgG4K monoclonal antibody specific for PD-1, in combination with gemcitabine and cisplatin (GP) has been approved as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) by the US FDA in October 2023. This is the first-in-human clinical trial (NCT05751486) to investigate the pharmacokinetics of toripalimab subcutaneous (SC) formulation in RM-NPC and determine the appropriate subcutaneous administration regimen for subsequent clinical trials. Methods Patients with histologically confirmed RM-NPC and without previously

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!